WordNet

(medicine) the act of caring for someone (as by medication or remedial training etc.); "the quarterback is undergoing treatment for a knee injury"; "he tried every treatment the doctors suggested"; "heat therapy gave the best relief"
type genus of the family Cancridae (同)genus Cancer
the fourth sign of the zodiac; the sun is in this sign from about June 21 to July 22 (同)Cancer the Crab, Crab
(astrology) a person who is born while the sun is in Cancer (同)Crab
a small zodiacal constellation in the northern hemisphere; between Leo and Gemini
any malignant growth or tumor caused by abnormal and uncontrolled cell division; it may spread to other parts of the body through the lymphatic system or the blood stream (同)malignant neoplastic disease
of or relating to or caused by hormones; "hormonal changes"

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 転移性ホルモン受容体陽性乳癌に対する治療アプローチ：内分泌療法 treatment approach to metastatic hormone receptor positive breast cancer endocrine therapy
2. 上皮性卵巣癌、卵管癌、および腹膜癌：疫学および危険因子 epithelial carcinoma of the ovary fallopian tube and peritoneum epidemiology and risk factors
3. 転移性前立腺癌の初期ホルモン療法 initial hormone therapy for metastatic prostate cancer
4. 乳癌に対する術前補助化学療法：理論的根拠、治療前評価、および治療法の選択肢 neoadjuvant therapy for breast cancer rationale pretreatment evaluation and therapeutic options
5. 女性の転移性乳癌に対する全身療法：化学療法 systemic treatment of metastatic breast cancer in women chemotherapy

Gogas H, Polyzos A, Kirkwood J.Source1st Department of Medicine, University of Athens, Medical School, Laikon General Hospital, Athens, Greece. Electronic address: hgogas@hol.gr.
Cancer treatment reviews.Cancer Treat Rev.2013 Dec;39(8):879-85. doi: 10.1016/j.ctrv.2013.04.006. Epub 2013 May 29.
The incidence of melanoma is increasing worldwide and despite early detection and intervention, the number of patients dying from metastatic disease continues to rise. The prognosis of advanced melanoma remains poor, with median survival between 6 and 9months. Over the past thirty years and despite
PMID 23725878

The aromatase inhibitors (plus ovarian function suppression) in premenopausal breast cancer patients: Ready for prime time?

Montagna E, Cancello G, Colleoni M.SourceDivision of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Electronic address: emilia.montagna@ieo.it.
Cancer treatment reviews.Cancer Treat Rev.2013 Dec;39(8):886-90. doi: 10.1016/j.ctrv.2013.04.007. Epub 2013 May 29.
Tamoxifen alone or the combination of ovarian function suppression (OFS) and tamoxifen are the mainstay of hormonal therapy in premenopausal women with endocrine-responsive breast cancer. The results of large trials conducted with the third generation of aromatase inhibitors (AIs) in the metastatic,
PMID 23725877

Management of high-risk prostate cancer: Radiation therapy and hormonal therapy.

Nomiya T, Tsuji H, Toyama S, Maruyama K, Nemoto K, Tsujii H, Kamada T.SourceNational Institute for Radiological Sciences, 4-9-1, Anagawa, Inage-ku, Chiba 263-8555, Japan. Electronic address: t_nomiya@nirs.go.jp.
Cancer treatment reviews.Cancer Treat Rev.2013 Dec;39(8):872-8. doi: 10.1016/j.ctrv.2013.04.003. Epub 2013 May 3.
The prognosis of high-risk prostate cancer is poor with a high mortality rate. The Radiation Therapy Oncology Group (RTOG) has performed dose-escalation studies of external beam radiation therapy (EBRT) and has developed high-precision radiation therapy (RT) methods such as intensity-modulated RT, c
PMID 23648323

Neoadjuvant hormonal therapy for low-risk prostate cancer induces biochemical recurrence after radical prostatectomy via increased lymphangiogenesis-related parameters